This DFE series of educational webinars looks at innovations in Oral Solid Dose Forms with the emergence of advanced technologies such as Continuous Manufacturing and 3D printing. The benefits and regulatory challenges will be explored, including how to manage the risk from the impact of excipient variability. In 3D the conflict between the novel materials which may be required, and regulatory acceptability, is a challenge. Perceived regulatory uncertainty may limit the widespread adoption of Continuous Manufacturing, despite the benefits of no scale-up and reduced risk of segregation.
The session will be of interest to personnel in R&D, Quality, and Regulatory.